标题
Effect of Prostanoids on Human Platelet Function: An Overview
作者
关键词
-
出版物
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 21, Issue 23, Pages 9020
出版商
MDPI AG
发表日期
2020-11-27
DOI
10.3390/ijms21239020
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Integration of Rap1 and Calcium Signaling
- (2020) Ramoji Kosuru et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- A Review of Prostanoid Receptors: Expression, Characterization, Regulation, and Mechanism of Action
- (2020) Roger G. Biringer Journal of Cell Communication and Signaling
- A novel approach of platelet function test for prediction of attenuated response to clopidogrel
- (2019) Erzsebet Ezer et al. CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
- Prostaglandin F2α Facilitates Platelet Activation by Acting on Prostaglandin E2 Receptor Subtype EP3 and Thromboxane A2 Receptor TP in Mice
- (2019) Hitoshi Kashiwagi et al. THROMBOSIS AND HAEMOSTASIS
- The pleiotropic effects of antiplatelet therapies
- (2019) Helen Ullrich et al. CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
- Measurement of Thromboxane Biosynthesis in Health and Disease
- (2019) Carlo Patrono et al. Frontiers in Pharmacology
- A Phase 2a Study of DP2 antagonist GB001 for Asthma
- (2019) Koichiro Asano et al. Journal of Allergy and Clinical Immunology-In Practice
- Oxygenation of polyunsaturated fatty acids and oxidative stress within blood platelets
- (2018) Michel Lagarde et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS
- Eicosanoids, prostacyclin and cyclooxygenase in the cardiovascular system
- (2018) Jane A Mitchell et al. BRITISH JOURNAL OF PHARMACOLOGY
- Eicosanoids in platelets and the effect of their modulation by aspirin in the cardiovascular system (and beyond)
- (2018) Marilena Crescente et al. BRITISH JOURNAL OF PHARMACOLOGY
- Bioresorbable everolimus-eluting vascular scaffold for patients presenting with non STelevation-acute coronary syndrome: A three-years follow-up1
- (2018) Remzi Anadol et al. CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
- Hypercoagulable state in sickle cell disease
- (2018) Camille Faes et al. CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
- Comparison of two substrate materials used as negative control in endothelialization studies: Glass versus polymeric tissue culture plate
- (2018) Anne Krüger-Genge et al. CLINICAL HEMORHEOLOGY AND MICROCIRCULATION
- Selectively targeting prostanoid E (EP) receptor-mediated cell signalling pathways: Implications for lung health and disease
- (2018) Leonard F. Lebender et al. PULMONARY PHARMACOLOGY & THERAPEUTICS
- Intracellular platelet signalling as a target for drug development
- (2018) Gemma Vilahur et al. VASCULAR PHARMACOLOGY
- Prostaglandin D2 receptor antagonists in allergic disorders: safety, efficacy, and future perspectives
- (2018) Giancarlo Marone et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Regulation and physiological functions of mammalian phospholipase C
- (2017) Yoshikazu Nakamura et al. JOURNAL OF BIOCHEMISTRY
- The expansive role of oxylipins on platelet biology
- (2017) Jennifer Yeung et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Prostanoids in the pathophysiology of human coronary artery
- (2017) G. Ozen et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Human Endothelial Cell Models in Biomaterial Research
- (2017) Sandra Hauser et al. TRENDS IN BIOTECHNOLOGY
- Targeting the Prostacyclin Pathway: Beyond Pulmonary Arterial Hypertension
- (2017) Hélène Pluchart et al. TRENDS IN PHARMACOLOGICAL SCIENCES
- Membrane Ballooning in Aggregated Platelets is Synchronised and Mediates a Surge in Microvesiculation
- (2017) Ejaife O. Agbani et al. Scientific Reports
- Platelets and coronary artery disease: Interactions with the blood vessel wall and cardiovascular devices
- (2016) Markus Reinthaler et al. Biointerphases
- New Developments in Platelet Cyclic Nucleotide Signalling: Therapeutic Implications
- (2016) Nathan E. K. Procter et al. CARDIOVASCULAR DRUGS AND THERAPY
- Phosphorylation of Rap1 by cAMP-dependent Protein Kinase (PKA) Creates a Binding Site for KSR to Sustain ERK Activation by cAMP
- (2016) Maho Takahashi et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Pharmacotherapy for Erectile Dysfunction: Recommendations From the Fourth International Consultation for Sexual Medicine (ICSM 2015)
- (2016) Konstantinos Hatzimouratidis et al. Journal of Sexual Medicine
- The effect of alprostadil on preventing contrast-induced nephropathy for percutaneous coronary intervention in diabetic patients
- (2016) Ziliang Ye et al. MEDICINE
- Treprostinil Iontophoresis Improves Digital Blood Flow during Local Cooling in Systemic Sclerosis
- (2016) Florence Gaillard-Bigot et al. MICROCIRCULATION
- Platelets and coronary artery disease: Interactions with the blood vessel wall and cardiovascular devices
- (2016) Markus Reinthaler et al. Biointerphases
- Acute Thrombogenicity of a Durable Polymer Everolimus-Eluting Stent Relative to Contemporary Drug-Eluting Stents With Biodegradable Polymer Coatings Assessed Ex Vivo in a Swine Shunt Model
- (2015) Fumiyuki Otsuka et al. JACC-Cardiovascular Interventions
- RAP1-GTPase signaling and platelet function
- (2015) Lucia Stefanini et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- Prostanoids regulate angiogenesis acting primarily on IP and EP 4 receptors
- (2015) Khuyen Gia Hoang et al. MICROVASCULAR RESEARCH
- Prostacyclin protects vascular integrity via PPAR/14-3-3 pathway
- (2015) Ling-yun Chu et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Understanding the role of prostaglandin E2 in regulating human platelet activity in health and disease
- (2015) Eitan A. Friedman et al. THROMBOSIS RESEARCH
- Prostacyclin Signaling Boosts NADPH Oxidase 4 in the Endothelium Promoting Cytoprotection and Angiogenesis
- (2014) Hitesh M. Peshavariya et al. ANTIOXIDANTS & REDOX SIGNALING
- Prostaglandin E3 metabolism and cancer
- (2014) Peiying Yang et al. CANCER LETTERS
- Reciprocal regulation of human platelet function by endogenous prostanoids and through multiple prostanoid receptors
- (2014) Katharina Hubertus et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Update on the status of DP2 receptor antagonists; from proof of concept through clinical failures to promising new drugs
- (2013) Peter Norman EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Prostaglandin F2α FP receptor antagonist improves outcomes after experimental traumatic brain injury
- (2013) Alexander V Glushakov et al. Journal of Neuroinflammation
- The role of prostaglandin E2 in human vascular inflammation
- (2013) I. Gomez et al. PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS
- Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010
- (2012) Rafael Lozano et al. LANCET
- Prostaglandin FP receptor inhibitor reduces ischemic brain damage and neurotoxicity
- (2012) Yun Tai Kim et al. NEUROBIOLOGY OF DISEASE
- The role of prostanoid receptors in mediating the effects of PGE3 on human platelet function
- (2012) David Iyú et al. THROMBOSIS AND HAEMOSTASIS
- Pulmonary Hypertension
- (2011) Ali Salehi AMERICAN JOURNAL OF THERAPEUTICS
- Novel roles of cAMP/cGMP-dependent signaling in platelets
- (2011) A. SMOLENSKI JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- The role of PGE2 in human atherosclerotic plaque on platelet EP3 and EP4 receptor activation and platelet function in whole blood
- (2011) Lisa J. Schober et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Terutroban versus aspirin in patients with cerebral ischaemic events (PERFORM): a randomised, double-blind, parallel-group trial
- (2011) Marie-Germaine Bousser et al. LANCET
- Degradable, Multifunctional Cardiovascular Implants: Challenges and Hurdles
- (2011) Friedrich Jung et al. MRS BULLETIN
- Arterial thrombus formation in cardiovascular disease
- (2011) Giuseppe Lippi et al. Nature Reviews Cardiology
- Omega-3 fatty acids attenuate constitutive and insulin-induced CD36 expression through a suppression of PPARα/γ activity in microvascular endothelial cells
- (2011) Rosalinda Madonna et al. THROMBOSIS AND HAEMOSTASIS
- The Prostaglandin E 2 Receptor EP4 Is Expressed by Human Platelets and Potently Inhibits Platelet Aggregation and Thrombus Formation
- (2010) Sonia Philipose et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Prostaglandin E2 Differentially Modulates Human Platelet Function through the Prostanoid EP2 and EP3 Receptors
- (2010) G. Petrucci et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- The role of prostanoid receptors in mediating the effects of PGE2on human platelet function
- (2010) David Iyú et al. PLATELETS
- PGE1 and PGE2 modify platelet function through different prostanoid receptors
- (2010) David Iyú et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
- Selective activation of the prostaglandin E2 receptor subtype EP2 or EP4 leads to inhibition of platelet aggregation
- (2010) Koh-ichi Yuhki et al. THROMBOSIS AND HAEMOSTASIS
- PGE2 decreases reactivity of human platelets by activating EP2 and EP4
- (2010) James P. Smith et al. THROMBOSIS RESEARCH
- PG F2α Receptor: A Promising Therapeutic Target for Cardiovascular Disease
- (2010) Jian Zhang et al. Frontiers in Pharmacology
- ACCF/AHA 2009 Expert Consensus Document on Pulmonary Hypertension
- (2009) et al. CIRCULATION
- Induction of Prostacyclin by Steady Laminar Shear Stress Suppresses Tumor Necrosis Factor-α Biosynthesis via Heme Oxygenase-1 in Human Endothelial Cells
- (2009) Luigia Di Francesco et al. CIRCULATION RESEARCH
- Prostaglandin F2 elevates blood pressure and promotes atherosclerosis
- (2009) Y. Yu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Modulation of angiogenesis by -3 polyunsaturated fatty acids is mediated by cyclooxygenases
- (2008) M. Szymczak et al. BLOOD
- DG-041 inhibits the EP3 prostanoid receptor—A new target for inhibition of platelet function in atherothrombotic disease
- (2008) Stan Heptinstall et al. PLATELETS
- Physiological Regulation of Prostaglandins in the Kidney
- (2007) Chuan-Ming Hao et al. Annual Review of Physiology
- The opposing effects of n−3 and n−6 fatty acids
- (2007) Gerd Schmitz et al. PROGRESS IN LIPID RESEARCH
- PGF2α-associated vascular smooth muscle hypertrophy is ROS dependent and involves the activation of mTOR, p70S6k, and PTEN
- (2007) K.M. Rice et al. PROSTAGLANDINS & OTHER LIPID MEDIATORS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started